This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v1.16.0: STU 2 Ballot 1) based on FHIR R4. The current version which supercedes this version is 2.0.0. For a full list of available versions, see the Directory of published versions
<MedicationRequest xmlns="http://hl7.org/fhir">
<id value="cancer-related-medication-request-cisplatin"/>
<meta>
<profile
value="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative</b></p><p><b>Treatment Intent</b>: <span title="Codes: {http://snomed.info/sct 373808002}">Curative - procedure intent</span></p><p><b>Termination Reason</b>: <span title="Codes: {http://snomed.info/sct 182992009}">Treatment completed (situation)</span></p><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: <span title="Codes: {http://www.nlm.nih.gov/research/umls/rxnorm 309311}">CISplatin 50 MG per 50 ML Injectable Solution</span></p><p><b>subject</b>: <a href="Patient-cancer-patient-john-anyperson.html">Generated Summary: Medical Record Number: m123 (USUAL); John B. Anyperson ; gender: male; birthDate: 1951-01-20</a></p><p><b>authoredOn</b>: 2019-04-01</p><p><b>requester</b>: <a href="Practitioner-us-core-practitioner-kyle-anydoc.html">Generated Summary: id: 9988776655; Kyle Anydoc ; gender: male</a></p><p><b>reasonCode</b>: <span title="Codes: {http://snomed.info/sct 254637007}">Non-small cell lung cancer (disorder)</span></p><p><b>note</b>: Day 1 of NSCLC regimen: Cisplatin 75 mg/m2 day 1; docetaxel 75 mg/m2 day 1 every 21 days for 4 cycles.</p><h3>DosageInstructions</h3><table class="grid"><tr><td>-</td></tr><tr><td>*</td></tr></table></div>
</text>
<extension
url="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-treatment-intent">
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="373808002"/>
<display value="Curative - procedure intent"/>
</coding>
</valueCodeableConcept>
</extension>
<extension
url="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-treatment-termination-reason">
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="182992009"/>
<display value="Treatment completed (situation)"/>
</coding>
</valueCodeableConcept>
</extension>
<status value="active"/>
<intent value="order"/>
<medicationCodeableConcept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="309311"/>
<display value="CISplatin 50 MG per 50 ML Injectable Solution"/>
</coding>
</medicationCodeableConcept>
<subject>
<reference value="Patient/cancer-patient-john-anyperson"/>
</subject>
<authoredOn value="2019-04-01"/>
<requester>
<reference value="Practitioner/us-core-practitioner-kyle-anydoc"/>
</requester>
<reasonCode>
<coding>
<system value="http://snomed.info/sct"/>
<code value="254637007"/>
<display value="Non-small cell lung cancer (disorder)"/>
</coding>
</reasonCode>
<note>
<text
value="Day 1 of NSCLC regimen: Cisplatin 75 mg/m2 day 1; docetaxel 75 mg/m2 day 1 every 21 days for 4 cycles."/>
</note>
<dosageInstruction>
<text value="calculate absolute dose on day of administration."/>
<timing>
<event value="2019-06-15"/>
<repeat>
<count value="1"/>
</repeat>
</timing>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="47625008"/>
<display value="Intravenous use"/>
</coding>
</route>
<doseAndRate>
<doseQuantity>
<value value="75"/>
<unit value="mg/m2"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg/m2"/>
</doseQuantity>
</doseAndRate>
</dosageInstruction>
</MedicationRequest>